mProbe is aiding oncologists in making informed clinical decisions by providing more comprehensive tumor profiling. And we can deliver more information with less tissue and in less time. With just 2 slides, our patented process allows us to identify over 70 sensitivity & resistance protein biomarkers and return actionable results in days, not weeks.

1. CMOS-Based Biochip System

Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive biological data. With high-throughput capabilities, this system is ideal for artificial intelligence (AI) analysis and applications in disease diagnosis and drug development. Its high integration and flexibility make it highly promising for precision medicine.

2. Nanowire Field Effect Transistor (FET) System

In partnership with Episil Technologies, Helios developed a nanowire FET system with ultra-high sensitivity for detecting trace biomarkers. This system is particularly suited for high-precision biological detection scenarios, such as early disease diagnosis or tracking specific biomarkers. Its exceptional sensitivity provides a unique advantage in trace analysis.